Sanara MedTech (SMTI) Other financing activities (2012 - 2026)

Sanara MedTech has reported Other financing activities for 9 years, with the latest figure at -$397219.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 130.44% year-over-year to -$397219.0; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 48.21% YoY), and the FY2025 full-year result was $183750.0, down 95.86% from the prior year.
• Other financing activities for Q1 2026 stood at -$397219.0, down from $948171.0 in the prior quarter.
• The five-year high for Other financing activities was $4.5 million in Q4 2024, with the low at -$1.0 million in Q3 2024.
• Historically, Other financing activities has averaged $1.4 million across 5 years, with a median of $1.1 million in 2023.
• Annual changes were most pronounced in 2022 — Other financing activities soared 434.5% — and 2024, when it slumped 219.58%.
• Sanara MedTech's Other financing activities stood at $3.9 million in 2022, then decreased by 7.72% to $3.6 million in 2023, then gained by 25.91% to $4.5 million in 2024, then slumped by 79.04% to $948171.0 in 2025, then plunged by 141.89% to -$397219.0 in 2026.
• The last three Other financing activities figures came in at -$397219.0 (Q1 2026), $948171.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.